J&J’s DePuy Synthes could sell to private equity for $20B: Report

Advertisement

Apollo Global Management is in discussions to acquire Johnson & Johnson’s orthopedics unit, DePuy Synthes, at a valuation close to $20 billion, Bloomberg reported Sept. 11, citing anonymous sources.

An agreement could be reached within weeks, though talks could end without an agreement or another bidder could emerge. J&J could also spin off the business as a publicly traded company.

DePuy Synthes, which makes devices used in hip and knee replacements, generated $9.3 billion in sales last year. J&J has said it would be the world’s largest orthopedics company if it becomes a standalone entity, the report said.

Johnson & Johnson CFO Joseph Wolk said in July that the company is on track for a mid-2027 separation, according to Bloomberg.

If the talks are successful, the acquisition would be Apollo’s biggest healthcare bet yet, following acquisitions including Brentwood, Tenn.-based Lifepoint Health and Louisville, Ky.-based Kindred Hospitals and a former majority stake in GI Alliance.

Advertisement

Next Up in Orthopedic

Advertisement